XXSC.L vs. NOV.DE

Last updated Jun 14, 2026

XXSC.L (Xtrackers MSCI Europe Small Cap UCITS ETF 1C) is Europe Equities fund tracking the MSCI Europe Small Cap NR EUR, while NOV.DE (Novo Nordisk A/S) is a stock. Over the past 10 years, XXSC.L returned 8.98%/yr vs 18.14%/yr for NOV.DE. At a 0.27 correlation, their price movements are largely independent.

Performance

XXSC.L vs. NOV.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Xtrackers MSCI Europe Small Cap UCITS ETF 1C (XXSC.L) and Novo Nordisk A/S (NOV.DE). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

XXSC.L is traded in GBp, while NOV.DE is traded in EUR. To make them comparable, the NOV.DE values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, XXSC.L achieves a 6.17% return, which is significantly higher than NOV.DE's -11.31% return. Over the past 10 years, XXSC.L has underperformed NOV.DE with an annualized return of 8.98%, while NOV.DE has yielded a comparatively higher 18.14% annualized return.

XXSC.L

• 1D: 1.71%
• 1M: 1.40%
• YTD: 6.17%
• 6M: 8.47%
• 1Y: 15.02%
• 3Y*: 11.34%
• 5Y*: 4.15%
• 10Y*: 8.98%

NOV.DE

• 1D: 0.19%
• 1M: -1.73%
• YTD: -11.31%
• 6M: -9.63%
• 1Y: -41.50%
• 3Y*: 4.58%
• 5Y*: 20.40%
• 10Y*: 18.14%

*Multi-year figures are annualized to reflect compound growth (CAGR)

XXSC.L vs. NOV.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
XXSC.L Xtrackers MSCI Europe Small Cap UCITS ETF 1C	6.17%	22.28%	0.76%	10.44%	-17.50%	15.39%	10.55%	24.37%	-14.57%	23.35%
NOV.DE Novo Nordisk A/S	-11.31%	-43.07%	-13.40%	195.59%	39.79%	64.46%	22.55%	31.75%	-6.04%	45.48%

Correlation

The correlation between XXSC.L and NOV.DE is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.22
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.23
Correlation (All Time) Calculated using the full available price history since Jan 17, 2008	0.27

The correlation between XXSC.L and NOV.DE shifts across timeframes, from 0.15 (3 years) to 0.27 (all time), reflecting how their relationship changes across market environments.

Return for Risk

XXSC.L vs. NOV.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XXSC.L

XXSC.L Risk / Return Rank: 32
XXSC.L Sharpe Ratio Rank: 33
XXSC.L Sortino Ratio Rank: 32
XXSC.L Omega Ratio Rank: 33
XXSC.L Calmar Ratio Rank: 29
XXSC.L Martin Ratio Rank: 32

NOV.DE

NOV.DE Risk / Return Rank: 12
NOV.DE Sharpe Ratio Rank: 9
NOV.DE Sortino Ratio Rank: 11
NOV.DE Omega Ratio Rank: 10
NOV.DE Calmar Ratio Rank: 12
NOV.DE Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XXSC.L vs. NOV.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Europe Small Cap UCITS ETF 1C (XXSC.L) and Novo Nordisk A/S (NOV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	XXSC.L	NOV.DE	Difference
Sharpe ratio: Return per unit of total volatility	1.06	-0.84	+1.90
Sortino ratio: Return per unit of downside risk	1.57	-1.04	+2.61
Omega ratio: Gain probability vs. loss probability	1.20	0.85	+0.35
Calmar ratio: Return relative to maximum drawdown	1.25	-0.80	+2.04
Martin ratio: Return relative to average drawdown	4.44	-1.17	+5.61

XXSC.L vs. NOV.DE - Sharpe Ratio Comparison

The current XXSC.L Sharpe Ratio is 1.06, which is higher than the NOV.DE Sharpe Ratio of -0.84. The chart below compares the historical Sharpe Ratios of XXSC.L and NOV.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

XXSC.L vs. NOV.DE - Drawdown Comparison

The maximum XXSC.L drawdown since its inception was -74.17%, roughly equal to the maximum NOV.DE drawdown of -75.63%. Use the drawdown chart below to compare losses from any high point for XXSC.L and NOV.DE.

Drawdown Indicators

	XXSC.L	NOV.DE	Difference
Max Drawdown Largest peak-to-trough decline	-74.17%	-75.63%	+1.46%
Max Drawdown (1Y) Largest decline over 1 year	-10.79%	-52.98%	+42.19%
Max Drawdown (3Y) Largest decline over 3 years	-19.10%	-75.63%	+56.53%
Max Drawdown (5Y) Largest decline over 5 years	-30.74%	-75.63%	+44.89%
Max Drawdown (10Y) Largest decline over 10 years	-35.75%	-75.63%	+39.88%
Current Drawdown Current decline from peak	-1.69%	-69.69%	+68.00%
Average Drawdown Average peak-to-trough decline	-20.66%	-11.01%	-9.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.04%	34.30%	-31.26%

Volatility

XXSC.L vs. NOV.DE - Volatility Comparison

The current volatility for Xtrackers MSCI Europe Small Cap UCITS ETF 1C (XXSC.L) is 3.81%, while Novo Nordisk A/S (NOV.DE) has a volatility of 9.45%. This indicates that XXSC.L experiences smaller price fluctuations and is considered to be less risky than NOV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XXSC.L	NOV.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.81%	9.45%	-5.64%
Volatility (6M) Calculated over the trailing 6-month period	10.66%	37.79%	-27.13%
Volatility (1Y) Calculated over the trailing 1-year period	12.66%	50.33%	-37.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.53%	57.12%	-36.59%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.31%	44.56%	-26.25%

Dividends

XXSC.L vs. NOV.DE - Dividend Comparison

XXSC.L has not paid dividends to shareholders, while NOV.DE's dividend yield for the trailing twelve months is around 4.10%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NOV.DE Novo Nordisk A/S	4.10%	3.54%	1.59%	1.02%	2.36%	2.54%	3.97%	4.18%	5.34%	4.55%	7.38%	2.50%
XXSC.L Xtrackers MSCI Europe Small Cap UCITS ETF 1C	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both XXSC.L and NOV.DE in my portfolio?

XXSC.L and NOV.DE have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.